AESKU.GROUP – A safe future thanks to quantitative AESKULISA® SARS-CoV-2 antibody tests
AESKU.GROUP, a leading biotechnology company, based in Wendelsheim, Germany, launched the first quantitative SARS-CoV-2 antibody tests in the 22nd calendar week. AESKU is currently the only company in the biotechnology industry, developing quantitative SARS-CoV-2 antibody tests that can certify the Mehr







